Duoneb and Hypoaesthesia oral - a phase IV clinical study of FDA data

Summary:

Hypoaesthesia oral is reported as a side effect among people who take Duoneb (albuterol sulfate; ipratropium bromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Advair Diskus 100/50, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Hypoaesthesia oral when taking Duoneb. It is created by eHealthMe based on reports of 8,008 people who have side effects when taking Duoneb from the FDA, and is updated regularly.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.

What is Hypoaesthesia oral?

Hypoaesthesia oral (reduced sense of touch or sensation in mouth) is found to be associated with 1,090 drugs and 1,013 conditions by eHealthMe. Check the latest studies of Hypoaesthesia oral.

On Jul, 13, 2026

8,008 people reported to have side effects when taking Duoneb.
Among them, 12 people (0.15%) have Hypoaesthesia oral.

Among these 12 people:

How long have people been on Duoneb when they have Hypoaesthesia oral? *

What is the gender of people who have Hypoaesthesia oral when taking Duoneb? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Hypoaesthesia oral when taking Duoneb? *

What are other drugs people take besides Duoneb? *

What are other side effects people have besides Hypoaesthesia oral? *

Dyspnea (difficult or laboured breathing): 5 people, 41.67%
Oral Discomfort (pain or irritation in mouth): 5 people, 41.67%
Weakness: 5 people, 41.67%
Metastases To Bone (cancer spreads to bone): 4 people, 33.33%
High Blood Pressure: 4 people, 33.33%
Osteoporosis (bones weak and more likely to break): 4 people, 33.33%
Osteosclerosis (an elevation in bone density): 4 people, 33.33%
Pain: 4 people, 33.33%
Pain In Extremity: 4 people, 33.33%
Joint Pain: 4 people, 33.33%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 3 people, 25.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 16.67%
Stress And Anxiety: 1 person, 8.33%
Metastases To Bone (cancer spreads to bone): 1 person, 8.33%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 8.33%
Lung Infection: 1 person, 8.33%
Dyspnea (difficult or laboured breathing): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Duoneb and have Hypoaesthesia oral?

- Check whether Hypoaesthesia oral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duoneb:

Duoneb (8,093 reports)

Hypoaesthesia oral treatments and more:

Hypoaesthesia oral (16,917 reports)

How severe was Hypoaesthesia oral and when was it recovered:

Hypoaesthesia oral in Duoneb

Expand to all the drugs that have ingredients of albuterol sulfate; ipratropium bromide:

Hypoaesthesia oral and drugs with ingredients of albuterol sulfate; ipratropium bromide (59 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoaesthesia oral:

Hypoaesthesia oral (1,090 drugs)

Browse all the conditions that are associated with Hypoaesthesia oral:

Hypoaesthesia oral (1,013 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide (the active ingredients of Duoneb) and Duoneb (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.